Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
Accounts Payable
{IF BankInsurance_zone 1}
$436 Mil (As of )Jun. 2016)
{IF AP_Q_zone 1}{ELSE} {/IF}

Alexion Pharmaceuticals Incs quarterly accounts payable declined from Dec. 2015 ($461 Mil) to Mar. 2016 ($461 Mil) but then increased from Mar. 2016 ($402 Mil) to Jun. 2016 ($436 Mil)

Alexion Pharmaceuticals Incs quarterly accounts payable increased from Dec. 2013 ($424 Mil) to Dec. 2014 ($424 Mil) and increased from Dec. 2014 ($439 Mil) to Dec. 2015 ($461 Mil)


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data


Alexion Pharmaceuticals Inc Annual Data

Accts Payable 27378078123178228424439461
{IF COMPANY->report_frequency 3M}

{COMPANY->company} Quarterly Data


{COMPANY->company} Semi-Annual Data

Accts Payable 241301439361454405461402436530

Accounts Payable does not apply to insurance companies.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)